New Injectable Treatment for Common Warts
Part of Infections, Skin clinical trials.
This study tests a new injection-based treatment for common warts (the bumpy growths on skin caused by a virus). Researchers want to see if this approach works better than current options and is safe for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have common warts that a doctor has confirmed by examining your skin
- You have not received any wart treatment for at least one month before joining
- Your warts are suitable for injection treatment
- You do not have serious chronic illnesses like diabetes, high blood pressure, or immune system disorders
- You are not pregnant, breastfeeding, or allergic to vitamin D
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two injected treatments (vitamin D3 or acyclovir) for common skin warts. The goal is to see which one works better for warts that are new or have not gone away with other treatments.
This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.
This study tests whether cantharidin—a liquid applied directly to common warts—can safely and effectively remove them. Common warts are bumpy growths caused by a virus that appear on hands, feet, and other body areas.
This study tests two treatments for common warts: a sclerotherapy injection and a candida antigen injection. The goal is to see which one works better to remove warts.
This Phase 3 trial tests a nonavalent HPV vaccine to treat long-lasting, hard-to-treat warts on the hands or feet. If you have tried standard treatments and the warts keep coming back or cause trouble, the vaccine may help your body clear the warts.
This trial compares two treatments for plantar warts: injecting vitamin D directly into the wart versus injecting acyclovir, an antiviral medicine. It aims to see which works better for clearing the warts.
Hear when a new Common Warts (Verruca Vulgaris) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.